TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Research Policy: NIH Trials Don’t Enroll Enough Women to Allow Analysis, GAO Says in Report May 12, 2000
TCL Archive In Brief: Larry Kun Was Named Clinical Director and Executive Vice President of St. Jude Children’s Research Hospital November 1, 2013
